Physiological functions and clinical implications of fibrinogen-like 2: A review.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26161303)

Published in World J Clin Infect Dis on August 25, 2013

Authors

Genyan Yang1, W Craig Hooper1

Author Affiliations

1: Clinical and Molecular Hemostasis Laboratory Branch, Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA 30301, United States.

Articles cited by this

Severe acute respiratory syndrome coronavirus phylogeny: toward consensus. J Virol (2004) 2.61

Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood (2001) 2.26

Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol (2001) 2.23

Microarray analysis of lymphatic tissue reveals stage-specific, gene expression signatures in HIV-1 infection. J Immunol (2009) 1.87

The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J Clin Invest (2003) 1.58

Cytokine-dependent abortion in CBA x DBA/2 mice is mediated by the procoagulant fgl2 prothrombinase [correction of prothombinase]. J Immunol (1998) 1.55

Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients: a FIPSE/GESIDA prospective cohort study. Liver Transpl (2012) 1.53

Structure of a cytotoxic T-lymphocyte-specific gene shows a strong homology to fibrinogen beta and gamma chains. Proc Natl Acad Sci U S A (1987) 1.38

Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells. J Immunol (2003) 1.20

Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection. J Gastroenterol Hepatol (2000) 1.17

Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis. J Immunol (2008) 1.16

Monoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus (MHV-3) infection. J Exp Med (1992) 1.15

Opposite regulation of type II and III receptors for immunoglobulin G in mouse glomerular mesangial cells and in the induction of anti-glomerular basement membrane (GBM) nephritis. J Biol Chem (2002) 1.15

Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J mice. J Virol (2006) 1.13

Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis. Am J Pathol (2000) 1.13

Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase. J Virol (1997) 1.08

Thrombin stimulates production of interleukin-8 in human umbilical vein endothelial cells. Immunology (1996) 1.05

Strain-specific T-cell suppression and protective immunity in patients with chronic hepatitis C virus infection. J Virol (2005) 1.03

Endothelial induction of fgl2 contributes to thrombosis during acute vascular xenograft rejection. J Immunol (2004) 1.03

Genomic characterization, localization, and functional expression of FGL2, the human gene encoding fibroleukin: a novel human procoagulant. Genomics (2001) 1.03

Characterization of human fibroleukin, a fibrinogen-like protein secreted by T lymphocytes. J Immunol (1998) 1.03

Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy? Kidney Int (2009) 1.03

The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis. Hepatology (2009) 1.01

Coronavirus MHV-3-induced apoptosis in macrophages. Virology (1998) 1.00

The nucleocapsid protein of murine hepatitis virus type 3 induces transcription of the novel fgl2 prothrombinase gene. J Biol Chem (1999) 0.99

Kinetic analysis of a unique direct prothrombinase, fgl2, and identification of a serine residue critical for the prothrombinase activity. J Immunol (2002) 0.99

Thrombin activates nuclear factor-kappaB and potentiates endothelial cell activation by TNF. J Immunol (1997) 0.98

Targeted deletion of Fgl-2/fibroleukin in the donor modulates immunologic response and acute vascular rejection in cardiac xenografts. Circulation (2005) 0.97

The FGL2-FcgammaRIIB pathway: a novel mechanism leading to immunosuppression. Eur J Immunol (2008) 0.97

Association of mouse fibrinogen-like protein with murine hepatitis virus-induced prothrombinase activity. J Virol (1995) 0.96

Effects of thrombin on myometrial contractions in vitro and in vivo. Am J Obstet Gynecol (2000) 0.95

Induction of prothrombinase fgl2 by the nucleocapsid protein of virulent mouse hepatitis virus is dependent on host hepatic nuclear factor-4 alpha. J Biol Chem (2003) 0.95

Novel mfgl2 antisense plasmid inhibits murine fgl2 expression and ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice. Hum Gene Ther (2006) 0.94

Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication. J Virol (1995) 0.93

Sequence of a human transcript expressed in T-lymphocytes and encoding a fibrinogen-like protein. Gene (1995) 0.92

Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B. World J Gastroenterol (2005) 0.91

Identification of genes associated with the progression of adult T cell leukemia (ATL). Jpn J Cancer Res (2000) 0.91

The mechanisms underlying the stimulatory effects of thrombin on myometrial smooth muscle. Am J Obstet Gynecol (2000) 0.91

The fgl2 prothrombinase/fibroleukin gene is required for lipopolysaccharide-triggered abortions and for normal mouse reproduction. Mol Hum Reprod (2004) 0.90

Intact type 1 immunity and immune-associated coagulative responses in mice lacking IFN gamma-inducible fibrinogen-like protein 2. Proc Natl Acad Sci U S A (2004) 0.90

Fgl2 prothrombinase expression in mouse trophoblast and decidua triggers abortion but may be countered by OX-2. Mol Hum Reprod (2001) 0.89

The novel immunoregulatory molecule FGL2: a potential biomarker for severity of chronic hepatitis C virus infection. J Hepatol (2010) 0.88

FGL2/fibroleukin mediates hepatic reperfusion injury by induction of sinusoidal endothelial cell and hepatocyte apoptosis in mice. J Hepatol (2011) 0.87

Intrahepatic expression of programmed death-1 and its ligands in patients with HBV-related acute-on-chronic liver failure. Inflammation (2013) 0.87

Nasopharyngeal shedding of severe acute respiratory syndrome-associated coronavirus is associated with genetic polymorphisms. Clin Infect Dis (2006) 0.87

Cytokine-induced hepatic apoptosis is dependent on FGL2/fibroleukin: the role of Sp1/Sp3 and STAT1/PU.1 composite cis elements. J Immunol (2006) 0.87

Expression of prothrombin and protease activated receptors in human myometrium during pregnancy and labor. Biol Reprod (2007) 0.87

Downregulation of FGL2/prothrombinase delays HCCLM6 xenograft tumour growth and decreases tumour angiogenesis. Liver Int (2012) 0.87

Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gamma. World J Gastroenterol (2008) 0.86

Gene transcription of fgl2 in endothelial cells is controlled by Ets-1 and Oct-1 and requires the presence of both Sp1 and Sp3. Eur J Biochem (2003) 0.86

The prothrombinase activity of FGL2 contributes to the pathogenesis of experimental arthritis. Scand J Rheumatol (2011) 0.86

Programmed death (PD)-1-deficient mice are extremely sensitive to murine hepatitis virus strain-3 (MHV-3) infection. PLoS Pathog (2011) 0.85

Hepatitis B virus-induced hFGL2 transcription is dependent on c-Ets-2 and MAPK signal pathway. J Biol Chem (2008) 0.84

The cytotoxic T lymphocyte gene FIBLP with homology to fibrinogen beta and gamma subunits is also induced in mouse macrophages by IFN-gamma. Cell Immunol (1995) 0.84

Expression of the fgl2 and its protein product (prothrombinase) in tissues during murine hepatitis virus strain-3 (MHV-3) infection. Adv Exp Med Biol (1998) 0.84

The emerging role of immunoregulation of fibrinogen-related procoagulant Fgl2 in the success or spontaneous abortion of early pregnancy in mice and humans. Am J Reprod Immunol (1999) 0.84

Dual interference with novel genes mfgl2 and mTNFR1 ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice. Hum Gene Ther (2010) 0.84

Expression of B and T lymphocyte attenuator (BTLA) in macrophages contributes to the fulminant hepatitis caused by murine hepatitis virus strain-3. Gut (2012) 0.84

Fgl2 deficiency causes neonatal death and cardiac dysfunction during embryonic and postnatal development in mice. Physiol Genomics (2007) 0.83

Plasma soluble fibrin monomer complex is a useful predictor of disseminated intravascular coagulation in neonatal sepsis. Haematologica (2005) 0.83

Severe acute respiratory syndrome (SARS): development of diagnostics and antivirals. Ann N Y Acad Sci (2006) 0.83

Activation of the novel prothrombinase, fg12, as a basis for the pregnancy complications spontaneous abortion and pre-eclampsia. Am J Reprod Immunol (2001) 0.83

Region-specific expression and secretion of the fibrinogen-related protein, fgl2, by epithelial cells of the hamster epididymis and its role in disposal of defective spermatozoa. J Biol Chem (2004) 0.82

Severe acute respiratory syndrome coronavirus nucleocapsid protein does not modulate transcription of the human FGL2 gene. J Gen Virol (2009) 0.81

The FGL2/fibroleukin prothrombinase is involved in alveolar macrophage activation in COPD through the MAPK pathway. Biochem Biophys Res Commun (2010) 0.80

MD-1 is a critical part of the mechanism causing Th1-cytokine-triggered murine fetal loss syndrome. Am J Reprod Immunol (2003) 0.79

Characterization of fibrinogen-like protein 2 (FGL2): monomeric FGL2 has enhanced immunosuppressive activity in comparison to oligomeric FGL2. Int J Biochem Cell Biol (2012) 0.79

Loss of resistance to murine hepatitis virus strain 3 infection after treatment with corticosteroids is associated with induction of macrophage procoagulant activity. J Virol (1996) 0.79

LPS-induced occult loss in mice requires FGL2. Am J Reprod Immunol (2007) 0.79

Identification of the receptor for FGL2 and implications for susceptibility to mouse hepatitis virus (MHV-3)-induced fulminant hepatitis. Adv Exp Med Biol (2006) 0.78

Polymorphonuclear leukocytes from patients with severe sepsis have lost the ability to degrade fibrin via u-PA. J Leukoc Biol (2004) 0.77

Cloning and tissue expression of the tissue prothrombinase Fgl-2 in the Sprague-Dawley rat. J Soc Gynecol Investig (2003) 0.77

Tissue prothrombinase activity in myometrium from timed-pregnant rats. J Soc Gynecol Investig (2006) 0.77

Candidate genes associated with susceptibility for SARS-coronavirus. Bull Math Biol (2009) 0.77

Infections in solid organ transplantation in special situations: HIV-infection and immigration. Enferm Infecc Microbiol Clin (2012) 0.76

The nucleocapsid protein of SARS-CoV induces transcription of hfgl2 prothrombinase gene dependent on C/EBP alpha. J Biochem (2008) 0.76

Excessive immunosuppression in kidney transplant patients: prevalence and outcomes. Transplant Proc (2012) 0.76

Treatment of resistant A/J mice with methylprednisolone (MP) results in loss of resistance to murine hepatitis strain 3 (MHV-3) and induction of macrophage procoagulant activity (PCA). Adv Exp Med Biol (1995) 0.76

Plasma fibrinogen-like protein 2 levels in patients with non-alcoholic fatty liver disease. Hepatogastroenterology (2012) 0.76

FGL2 prothrombinase messenger RNA expression in gravid and nongravid human myometrium. Am J Obstet Gynecol (2003) 0.76

Increased circulating fibrinogen-like protein 2 in patients with systemic sclerosis. Clin Rheumatol (2012) 0.76